Zylox-Tonbridge Medical Technology Co., Ltd. - ROE
2190.HK
Price:
$20.34
Market Cap:
$5.31B
Zylox-Tonbridge Medical Technology Co., Ltd. is a global medical device firm specializing in neurovascular and peripheral vascular interventional technologies. Their comprehensive product line for treating ischemic stroke includes the ThromBite Clot Retriever, designed to extract clots from major brain vessels, as well as aspiration and balloon guiding catheters. For peripheral vascular conditions, they offer the ZENFLEX Pro Drug-eluting Stent System for managing complex and recurring symptomatic lesions, the self-expanding ZENFlex Peripheral Stent System for deployment in the iliac, superficial femoral, and proximal popliteal arteries, and drug-coated Percutaneous Transluminal Angioplasty (...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-05
Stock Exchange
HKSE
Ticker
2190.HK
PE Ratio
[18.82]
ROE
[9.76%]
Current Ratio
[4.67]
Dividend Yield
[1.77%]
Enterprise Value
[4.88B]
Dividend History
The ROE as of October 2026 (TTM) for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) is 9.76%
According to Zylox-Tonbridge Medical Technology Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 9.76%. This represents a change of 165.35% compared to the average of 3.68% of the last 4 quarters.
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) Historical ROE (quarterly & annually)
How has 2190.HK ROE performed in the past?
The mean historical ROE of Zylox-Tonbridge Medical Technology Co., Ltd. over the last ten years is -9.38%. The current 9.76% ROE has changed -203.98% with respect to the historical average. Over the past ten years (40 quarters), 2190.HK's ROE was at its highest in in the June 2026 quarter at 6.11%. The ROE was at its lowest in in the December 2019 quarter at -19.54%.
Average
-9.38%
Median
-3.67%
Minimum
-40.23%
Maximum
7.56%
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) ROE by Quarter and Year
Discovering the peaks and valleys of Zylox-Tonbridge Medical Technology Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 133.93%
Maximum Annual ROE = 7.56%
Minimum Annual Increase = -225.13%
Minimum Annual ROE = -40.23%
| Year | ROE | Change |
|---|---|---|
| 2025 | 7.56% | 133.93% |
| 2024 | 3.23% | -225.13% |
| 2023 | -2.58% | -29.60% |
| 2022 | -3.67% | -42.21% |
| 2021 | -6.35% | -73.16% |
| 2020 | -23.66% | -41.19% |
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) Average ROE
How has 2190.HK ROE performed in the past?
The current ROE of Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.74%
5-year avg
-0.36%
10-year avg
-9.38%
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) ROE vs. Peers
How is 2190.HK’s ROE compared to its peers?
Zylox-Tonbridge Medical Technology Co., Ltd.’s ROE is less than Shanghai HeartCare Medical Technology Corporation Limited (7.90%), greater than Acotec Scientific Holdings Limited (-3.50%), greater than Peijia Medical Limited (-7.65%), less than LifeTech Scientific Corporation (1.71%), less than Shanghai Kindly Medical Instruments Co., Ltd. (9.64%), less than LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (10.01%), less than OrbusNeich Medical Group Holdings Limited (10.50%), greater than Broncus Holding Corporation (-12.45%),
| Company | ROE | Market cap |
|---|---|---|
| 7.90% | $2.13B | |
| -3.50% | $1.77B | |
| -7.65% | $2.89B | |
| 1.71% | $6.16B | |
| 9.64% | $4.93B | |
| 10.01% | $4.53B | |
| 10.50% | $3.12B | |
| -12.45% | $318.58M |
Build a custom stock screener for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zylox-Tonbridge Medical Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Zylox-Tonbridge Medical Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Zylox-Tonbridge Medical Technology Co., Ltd.'s ROE?
How is the ROE calculated for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)?
What is the highest ROE for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)?
What is the 3-year average ROE for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)?
What is the 5-year average ROE for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)?
How does the current ROE for Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) compare to its historical average?